ENG and neoplasm: Here, we showed that combination of antiangiogenic drug and immunostimulatory agent like the endoglin-based DNA vaccine with IL-12 can repolarize TAMs phenotype from M2-like (tumor growth-promoting) into M1-like (tumor growth-inhibiting) which affects the structure of tumor blood vessels, tumor infiltration by immune cells and tumor regression (Fig 11).